Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain

K Funa, N Yamada, G Brodin, K Pietz, A Åhgren… - Neuroscience, 1996 - Elsevier
K Funa, N Yamada, G Brodin, K Pietz, A Åhgren, K Wictorin, O Lindvall, P Odin
Neuroscience, 1996Elsevier
The kinetics of platelet-derived growth factor messenger RNA synthesis in the substantia
nigra and in the striatum, before and after unilateral intranigral 6-hydroxydopamine injection,
was studied and compared with that after sham operation by a quantitative reverse
transcription–polymerase chain reaction. The kinetics of brain-derived neurotrophic factor
messenger RNA was studied as a comparison. Furthermore, the expression of platelet-
derived growth factor A-and B-chain proteins was analysed by enzyme-linked …
The kinetics of platelet-derived growth factor messenger RNA synthesis in the substantia nigra and in the striatum, before and after unilateral intranigral 6-hydroxydopamine injection, was studied and compared with that after sham operation by a quantitative reverse transcription–polymerase chain reaction. The kinetics of brain-derived neurotrophic factor messenger RNA was studied as a comparison. Furthermore, the expression of platelet-derived growth factor A- and B-chain proteins was analysed by enzyme-linked immunosorbent assay and immunohistochemistry. In the ipsilateral striatum of 6-hydroxydopamine-lesioned rats, the signal density of messenger RNA for both A- and B-chains had already increased at one day and remained at an elevated level during the observation period of four weeks. In the substantia nigra ipsilateral to the lesion, a strongly increased level of B-chain and, to a lesser extent, of A-chain messenger RNA was already detected at 4h, reaching a maximal level at one day. No significant increase was seen either in sham-operated rats or in the contralateral striatum and substantia nigra. Amounts of platelet-derived growth factor proteins were examined separately by enzyme-linked immunosorbent assay in both sides of the substantia nigra, striatum and cortex. Three days after 6-hydroxydopamine lesions the levels of both platelet-derived growth factor A- and B-chains increased in the ipsilateral striatum, substantia nigra, and cortex. An increase in the A-chain was also observed in the contralateral side of the brain. The signal for brain-derived neurotrophic factor messenger RNA increased in the striatum in the lesioned side and, to a lesser extent, in the contralateral side, as well as the in the substantia nigra, where a significant difference was observed when compared with the contralateral side. Semiquantitative immunohistochemical analysis on the substantia nigra confirmed the enhanced platelet-derived growth factor expression, revealing that the majority of the platelet-derived growth factor-producing cells were neurons. In summary, we have shown that platelet-derived growth factor messenger RNA as well as its protein are induced after injury to dopaminergic cells. These data indicate an important role of platelet-derived growth factor in the dopaminergic system.
Elsevier